Page 42 - Read Online

Hafezi et al. Hepatoma Res 2020;6:23 I http://dx.doi.org/10.20517/2394-5079.2020.02 Page 7 of 7

30. Ling S, Hu Z, Yang Z, Yang F, Li Y, et al. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian
cell evolution. Proc Natl Acad Sci U S A 2015;112:E6496-505.
31. Duan M, Hao J, Cui S, Worthley DL, Zhang S, et al. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma
revealed by single-cell genome sequencing. Cell Res 2018;28:359-73.
32. Hafezi M, Bertoletti A, Tan AT. T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma. Hepatoma Res 2018;4:16.
33. Pillai AA, Levitsky J. Overview of immunosuppression in liver transplantation. World J Gastroenterol 2009;15:4225-33.
34. Pavesi A, Tan AT, Koh S, Chia A, Colombo M, et al. A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells
against solid tumors. JCI Insight 2017;2.
35. De Angelis B, Dotti G, Quintarelli C, Huye LE, Zhang L, et al. Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes
resistant to the immunosuppressive drug tacrolimus (FK506). Blood 2009;114:4784-91.
36. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi
IL-17-secreting T cells. Blood 2011;117:1250-9.
37. Kurioka A, Walker LJ, Klenerman P, Willberg CB. MAIT cells: new guardians of the liver. Clin Transl Immunol 2016;5:e98.
38. Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR. A distinct subset of self-renewing human memory CD8+ T cells survives
cytotoxic chemotherapy. Immunity 2009;31:834-44.